Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...
Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian cancer HOLON, Israel, Oct. 13, ...
The German biotech banked one of the larger funding rounds this year to support an ovarian and non-small cell lung cancer ...
Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a ...
The Phase 1 results and Cyclin E1 biomarker findings accepted for presentation at AACR-NCI-EORTC reinforce our biomarker-driven strategy for azenosertib in Cyclin E1-positive platinum-resistant ...
The U.S. Food and Drug Administration (FDA) is reviewing Corcept’s application to market relacorilant in the United States to treat patients with platinum-resistant ovarian cancer. The FDA’s ...
When Angelina Reardon went in for a routine scan in 2021, she never imagined her life was about to change forever. What ...
FARGO, N.D. (Valley News Live) - A 20-year-old college student from the Fargo-Moorhead area is turning her unexpected cancer ...
JUPITER, Fla. — WPTV is celebrating the strength of a Jupiter mother who was diagnosed with stage 4b, the most advanced stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback